T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Savara
SVRA
$1.08B
| $127K | ﹤0.01% |
55,667
+3,545
| +7% | +$9.64K |
|
|
TSE
2827
DELISTED
Trinseo
TSE
| $127K | ﹤0.01% |
40,483
+16,583
| +69% | +$54.7K |
|
2828
Vanda Pharmaceuticals
VNDA
$304M
| $127K | ﹤0.01% |
26,765
| – | – |
|
2829
Satellogic
SATL
$906M
| $126K | ﹤0.01% |
+34,579
| New | +$130K |
|
2830
Abeona Therapeutics
ABEO
$361M
| $125K | ﹤0.01% |
+21,909
| New | +$125K |
|
|
SKYT
2831
DELISTED
SkyWater Technology
SKYT
| $124K | ﹤0.01% |
12,556
+321
| +3% | +$2.59K |
|
|
CHMI
2832
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $123K | ﹤0.01% |
44,762
| – | – |
|
2833
Compass Therapeutics
CMPX
$407M
| $123K | ﹤0.01% |
46,942
| – | – |
|
2834
Ironwood Pharmaceuticals
IRWD
$674M
| $123K | ﹤0.01% |
172,521
+1,243
| +0.7% | +$976 |
|
2835
The ONE Group
STKS
$56.8M
| $123K | ﹤0.01% |
30,305
-8,485
| -22% | -$29.2K |
|
2836
American Coastal Insurance
ACIC
$461M
| $122K | ﹤0.01% |
10,957
| – | – |
|
|
SRTA
2837
Strata Critical Medical Inc
SRTA
$528M
| $122K | ﹤0.01% |
30,150
+5,342
| +22% | +$17.4K |
|
|
KGEI
2838
Kolibri Global Energy
KGEI
$200M
| $122K | ﹤0.01% |
+17,699
| New | +$122K |
|
2839
Mammoth Energy Services
TUSK
$154M
| $122K | ﹤0.01% |
43,285
+16,812
| +64% | +$43K |
|
2840
Oportun Financial
OPRT
$351M
| $121K | ﹤0.01% |
+16,796
| New | +$101K |
|
2841
Organogenesis Holdings
ORGO
$226M
| $121K | ﹤0.01% |
32,889
+3,997
| +14% | +$14.9K |
|
2842
Gossamer Bio
GOSS
$83.3M
| $118K | ﹤0.01% |
95,291
+30,514
| +47% | +$33.3K |
|
2843
Editas Medicine
EDIT
$432M
| $117K | ﹤0.01% |
53,137
+9,360
| +21% | +$15.3K |
|
2844
Viemed Healthcare
VMD
$349M
| $117K | ﹤0.01% |
16,901
+2,141
| +15% | +$14.5K |
|
|
ATXS
2845
DELISTED
Astria Therapeutics
ATXS
| $116K | ﹤0.01% |
21,517
+1,327
| +7% | +$6.43K |
|
2846
Blue Ridge Bankshares
BRBS
$336M
| $116K | ﹤0.01% |
+32,261
| New | +$109K |
|
2847
Savers
SVV
$1.67B
| $116K | ﹤0.01% |
+11,351
| New | +$111K |
|
2848
Tyra Biosciences
TYRA
$1.49B
| $116K | ﹤0.01% |
+12,022
| New | +$114K |
|
2849
Krispy Kreme
DNUT
$569M
| $115K | ﹤0.01% |
39,321
+1,507
| +4% | +$5.26K |
|
2850
Tredegar Corp
TG
$278M
| $115K | ﹤0.01% |
12,988
+519
| +4% | +$4.19K |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.